Sponsored Ad | Nikkei Forum Medini Johor - Leaderboard

Temasek leads $50m Series B in digital health firm PEAR Therapeutics, EDBI joins round

Temasek leads $50m Series B in digital health firm PEAR Therapeutics, EDBI joins round

A Temasek Holdings Pte employee walks past the company's signage in their office in Singapore. Photographer: Munshi Ahmed/Bloomberg

Juliet Shwe Gaung

03 January, 2018

Singapore’s state-run investment firm Temasek Holdings Private Ltd led a $50 million Series B investment in US-based digital health firm PEAR Therapeutics.

5AM VenturesArboretum VenturesAZZ Venture PartnersBridge Builder’s CollaborativeedbiJAZZ Venture PartnersNovartisPEAR TherapeuticsTemasekthe Bridge Builder’s collaborative

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Singapore

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.